The biotechnology company posted revenue of $498,000 in the period. Ocular Therapeutix shares have increased 22 percent since the beginning of ...
News
- Ocular Therapeutix: 3Q Earnings Snapshot
- Kindred Bio: 3Q Earnings Snapshot
BURLINGAME, Calif. (AP) _ Kindred Biosciences Inc. (KIN) on Wednesday reported a loss of $13 million in its third quarter. On a per-share basis, the ...
- Power to the People: How Energy Works on the Blockchain and Why Entrepreneurs Should Pay ...
... responsible for not halting irreversible climate change. Related: #5 Ways Through Which Biotech Entrepreneurs are Going to Enhance Human Lives ...
- Tiny molecule has big effect in childhood brain tumor studies
SAN ANTONIO--Sometimes small things make the biggest differences. A new study by UT Health San Antonio researchers found that a molecule ... nursing, dentistry, health professions and graduate biomedical sciences have ...
- Momenta: 3Q Earnings Snapshot
The biotechnology company posted revenue of $14.9 million in the period. Momenta shares have increased slightly more than 3 percent since the ...
